ERANOV PHARMA
ActiveERANOV PHARMA has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €89k and a net result of €11k. Equity is growing by ~19.5% per year across the filed fiscal years. Its solvency ranks better than 57% of 3478 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
63
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability52▲+35
Solvency83▼-12
Growth52=
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €5k at 30 days acceptable
Liquidity ample (current ratio 2.23 against 2.97 in 2024; short-term debt: 42% and cash: 0.1% of total assets), and 42% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 74
Relative position
BE, all sectors
reference
Sector 74
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
58%
Return on assets
7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-07-2026, 13 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
13 d early
2024
44 d early
2023
62 d early
2022
70 d late
2021
31 d late
2020
31 d late
2019
26 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Turnover
€119k
EBIT margin
26.1%
Net result
€11k
2024 · €-3k
2019: €15k
2020: €7k
2021: €17k
2022: €24k
2023: €16k
2024: €-3k
2019 → 2025
Working capital
€79k▲ 18.9%
2024 · €67k
2019: €16k
2020: €22k
2021: €38k
2022: €60k
2023: €68k
2024: €67k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€119k
Equity€40k-€65k▲ 60.2%€81k▲ 25.3%€78k▼ 3.6%€89k▲ 13.8%
Operating result€23k-€31k▲ 32.6%€23k▼ 27.3%€-97€18k
Net result€17k-€24k▲ 42.4%€16k▼ 32.8%€-3k€11k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2025: €18k after a loss of €97 in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €153k
Fixed assets
€9k▼ 16.8%
Current assets
€144k▲ 42.7%
Equity and liabilities €153k
Equity
€89k▲ 13.8%
Debt
€64k▲ 89.4%
The debt ratio rises from 30.3% to 42.0%. Equity and debt are higher.
Key figures and ratios
EBITDA
€20k▲
2024 · €2k
Cash flow
€13k▲
2024 · €-697
Solvency
58.0%▼
2024 · 69.7%
Current ratio
2.23▼
2024 · 2.97
Quick ratio
2.23▼
2024 · 2.97
Debt / equity
0.72▲
2024 · 0.44
ROE
12.1%▲
2024 · -3.7%
ROA
7.0%▲
2024 · -2.6%
Interest coverage
2.98▲
2024 · 0.23
Debt
€64k▲
2024 · €34k
Debt ≤ 1 year
€64k▲
2024 · €34k
Income taxes
€5k▲
2024 · €677
Staff costs
€0▼
2024 · €28
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€112k€153k▲
Fixed assets21/28€11k€9k▼
Tangible fixed assets22/27€11k€9k▼
Plant, machinery and equipment23€10k€9k▼
Furniture and vehicles24€1k€563▼
Current assets29/58€101k€144k▲
Amounts receivable after more than one year29€69k€69k=
Other amounts receivable291€69k€69k=
Amounts receivable within one year40/41€31k€74k▲
Trade receivables40€30k€58k▲
Other amounts receivable41€972€16k▲
Cash at bank and in hand54/58€148€111▼
Deferred charges and accrued income490/1€0€281▲
Equity and liabilities
Total equity and liabilities10/49€112k€153k▲
Equity10/15€78k€89k▲
Contributions10/11€2k€2k=
Profit (loss) carried forward14€76k€87k▲
Amounts payable17/49€34k€64k▲
Amounts payable within one year42/48€34k€64k▲
Financial debts43-€4k
Credit institutions430/8-€4k
Trade debts44€26k€35k▲
Suppliers440/4€26k€35k▲
Taxes, remuneration and social security45€6k€17k▲
Taxes450/3€4k€15k▲
Remuneration and social security454/9€3k€3k=
Other amounts payable47/48€1k€8k▲
Income statement
Code20242025
Non-recurring operating income76A€5k€0▼
Remuneration, social security and pensions62€28€0▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€2k▼
Other operating charges640/8€829€3k▲
Non-recurring operating charges66A-€11k
Gross operating margin9900€3k€34k▲
Operating profit (loss)9901€-97€18k▲
Financial income75/76B€7k€5k▼
Recurring financial income75€7k€5k▼
Financial charges65/66B€9k€7k▼
Recurring financial charges65€9k€7k▼
Profit (loss) for the period before taxes9903€-2k€16k▲
Income taxes67/77€677€5k▲
Profit (loss) for the period9904€-3k€11k▲
Profit (loss) for the period to be appropriated9905€-3k€11k▲
Appropriation of the result
Profit (loss) to be appropriated9906€76k€87k▲
Profit (loss) brought forward from the previous period14P€79k€76k▼
The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
18-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Back to profitnet €11k
Net result €11k after one loss-making year.
17-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Weakest financial yearnet €-3k ▼118%
Net result drops to €-3k, the lowest in the series; recovery starts the following year.
30-05
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
09-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 70 days late
2022
31-12
Financial
Highest result since 2019net €24k ▲42.4%
Operating result €31k, net result €24k, both a record.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
26-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 26 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Mouscron · 1 establishment unit since 2019
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Jean Jaurèslaan 1187700 MouscronGround area
3,876 m²
Building footprint
554 m²
Volume, LiDAR
4,333 m³
2 parcels, Wallonia · tallest building 13.9 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
ERANOV PHARMA
since 20192.296.853.892
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 51004C0037/00E004 | Wallonia | 3,568 m² | 1 · 502 m² | 13.9 m · 3 fl. |
| 54434F0982/00T002 | Wallonia | 307 m² | 1 · 52 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
MSCC-CONSULT
BE 0792.982.423
Boortmeerbeek · Eq €89k
SOVE MILIEU- EN VEILIGHEIDSCONSULTING
BE 0807.091.765
Merelbeke-Melle · Eq €89k
CONSULTHENA
BE 1018.535.929
Yvoir · Eq €88k
AVDA-Service
BE 0801.312.347
Zoersel · Eq €89k
TROMO WOOD
BE 0715.972.341
Chiny · Eq €88k
Of 4,567 companies in sector 74999 we hold annual accounts for 1,938. 1,560 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded09-12-2019
Fiscal year end31-12
Activities, NACEBEL
74909Other professional, scientific and technical activities
74999Other professional, scientific and technical activities
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.